论文部分内容阅读
卡维地洛是一种非选择性β受体阻滞剂,其抗心律失常作用已被动物实验和临床研究所证实。它主要治疗心力衰竭合并心房颤动、急性及陈旧性心肌梗死后室性心律失常和再灌注心律失常。现对近几年国内外文献关于卡维地洛抗心律失常研究进行综述。
Carvedilol is a non-selective beta-blocker whose antiarrhythmic effects have been demonstrated in animal experiments and clinical studies. It is mainly used to treat heart failure with atrial fibrillation, ventricular arrhythmias and reperfusion arrhythmias after acute and old myocardial infarction. Now in recent years, domestic and foreign literature on anti-arrhythmia carvedilol are reviewed.